Jnana Therapeutics

Jnana Therapeutics is a company in Boston, United States. Its scientists work on unlocking the potential of chemoproteomics to uncover unique binding sites on highly validated protein targets and to accelerate the discovery of new molecules. The company describes a RAPID platform that allows it to systematically develop small molecule medicines for any target class, and states that it is advancing first- and best-in-class therapies to treat phenylketonuria (PKU) and a broad range of immune-mediated diseases. Jnana also reports a collaboration with Roche, under which it announced an additional pre-clinical milestone.

Jnana Therapeutics is a company in Boston, United States. It describes its work as unlocking the full potential of chemoproteomics to uncover unique binding sites on highly validated protein targets and accelerate the discovery of new molecules that can change the course of disease. The company states that its RAPID platform allows it to systematically develop small molecule medicines for any target class, and that it is advancing first- and best-in-class therapies to treat phenylketonuria (PKU) and a broad range of immune-mediated diseases. Jnana also announced an additional pre-clinical milestone achieved under a first collaboration with Roche.

Outpacing conventional drug discovery to unlock the full potential of high value targets

1. 1HOME | Jnana Therapeuticsjnanatx.com
2. 2Jnana Therapeutics (United States)wikidata.org